|
1.
Lack of Medication Dose Uniformity in Commonly Split Tablets In this study, half-tablets were evaluated for their uniformity through ... Each tablet was split, resulting in 20 fragments. Each half-tablet was weighed. ... 2.
Torcetrapib Significantly Increases HDL Cholesterol Levels Apr 7, 2004 ... Torcetrapib at a dose of 120 mg daily increased HDL cholesterol levels by 61% compared with placebo in subjects also receiving atorvastatin ... 3.
Innovative Treatment Strategies in Non-Small Cell Lung Cancer Jeremic et al[25] found that patients receiving HFRT and daily concurrent chemotherapy had a significant improvement in local recurrence-free survival (42% ... 4.
Gamimune N IV: Dosage, Uses and Warnings Dosage, Uses and Warnings from Medscape Drug Reference. 5.
Essay: Doctors of Interrogation See the International Covenant on Civil and Political Rights (1966) 999 U.N.T.S. 171 (ICCPR) and the Convention against Torture and Other Cruel, ... 6.
EXFORGE | Industry information for EXFORGE At week 2, patients were force-titrated to amlodipine 10 mg QD or EXFORGE 10/160 mg QD. At week 4, patients with SBP ≥130 mm Hg had open-label HCTZ 12.5 mg ... 7.
EXFORGE | Industry information for EXFORGE At week 2, patients were force-titrated to amlodipine 10 mg QD or EXFORGE 10/160 mg ... mm Hg) were randomized to amlodipine 5 mg QD or EXFORGE 5/160 mg QD. ... 8.
EXFORGE | Industry information for EXFORGE In patients with severe hypertension, EXFORGE was able to achieve powerful ... Hg and <200 mm Hg) were randomized to amlodipine 5 mg QD or EXFORGE 5/160 QD. ... 9.
EXFORGE | Industry information for EXFORGE At week 4, patients on EXFORGE 10/160 QD with SBP ≥130 mm Hg were titrated to EXFORGE 10/320 mg QD, and patients on amlodipine 10 mg QD continued the ... 10.
EXFORGE | Industry information for EXFORGE At week 4, patients on EXFORGE 10/160 QD with SBP ≥130 mm Hg were titrated to EXFORGE 10/320 mg QD, and patients on amlodipine 10 mg QD continued the ... |
